Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P6MW
|
|||
| Former ID |
DNCL003483
|
|||
| Drug Name |
Imprime PGG
|
|||
| Synonyms |
Imprime PGG (TN)
Click to Show/Hide
|
|||
| Indication | Non-hodgkin lymphoma [ICD-11: 2B33.5] | Phase 2/3 | [1] | |
| Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [2] | ||
| Head and neck cancer [ICD-11: 2D42] | Phase 2 | [2] | ||
| Colorectal cancer [ICD-11: 2B91.Z] | Phase 1/2 | [2] | ||
| Melanoma [ICD-11: 2C30; ICD-9: 172] | Phase 1/2 | [2], [3] | ||
| Company |
Biothera
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024408) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 4 | National Cancer Institute Drug Dictionary (drug id 599816). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.